Synapse pathology in Alzheimer's disease.

¹Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK; Dementia Research Institute at Imperial College, Department of Brain Sciences, Imperial College London, London W12 0NN, UK.

Seminars in Cell & Developmental Biology

|June 11, 2022

Summary

This review explores how synapses are affected in Alzheimer's disease. Synapses are connections between brain cells, and their loss is linked to cognitive decline. The authors examine evidence from microscopy and molecular studies to understand how Aβ, tau, and glial cells affect synapses. They also consider mitochondrial dysfunction and genetic risk factors. The review highlights a new perspective: synapse diversity may play a role in disease progression. Synaptome mapping methods could help identify vulnerable and resilient synapses. These findings may guide future treatments aimed at preserving synapses. The authors emphasize the need for more research on synapse diversity in AD.

Area of Science:

Neurodegenerative disease research in clinical neuroscience
Synaptic plasticity within molecular biology

Background:

Synapse dysfunction is a hallmark of Alzheimer's disease, but the mechanisms remain unclear. Prior research has shown that synapse loss correlates with cognitive decline. However, the precise role of Aβ and tau in synapse damage is debated. Glial cell involvement in synaptic changes is also poorly understood. Mitochondrial dysfunction is linked to synapse vulnerability, but how it interacts with other factors is unclear. AD risk genes may influence synapse resilience, but the pathways are not fully mapped. This gap motivated researchers to synthesize current evidence on synapse pathology. That uncertainty drove a review of synapse architecture and diversity in AD.

Purpose Of The Study:

The aim is to summarize synapse pathology in Alzheimer's disease. This includes reviewing evidence from microscopy and molecular studies. The focus is on how Aβ, tau, and glial cells affect synapses. Researchers also examine mitochondrial dysfunction and genetic risk factors. The goal is to understand synapse diversity in AD. This review considers how synapse diversity may influence disease progression. The motivation is to guide future therapeutic strategies. The study aims to clarify the role of synapse diversity in AD.

Main Methods:

The researchers conducted a literature review on synapse pathology in AD. They analyzed findings from microscopy and molecular studies. They examined the role of Aβ, tau, and glial cells in synapse damage. They also considered mitochondrial dysfunction and genetic risk factors. The review included studies on synapse architecture and diversity. They assessed the impact of AD on synapse resilience and vulnerability. The researchers evaluated how synapse diversity may affect disease progression. They discussed emerging synaptome mapping methods in the context of AD.

Main Results:

Synapse loss and damage are central to AD progression. Aβ and tau contribute to synapse dysfunction, but their exact roles vary. Glial cells may both protect and damage synapses in AD. Mitochondrial dysfunction is linked to synapse vulnerability. AD risk genes influence synapse resilience and diversity. Synapse diversity appears to be a key factor in AD pathology. Synaptome mapping methods may help identify vulnerable synapses. The review highlights the need for further research on synapse diversity.

Conclusions:

The review suggests that synapse pathology in AD involves multiple factors. Aβ, tau, and glial cells play roles in synapse damage. Mitochondrial dysfunction and genetic risk factors also contribute. Synapse diversity may be a new level of synapse pathology in AD. Synaptome mapping methods could improve understanding of synapse vulnerability. The findings may inform therapeutic strategies targeting synapse preservation. The review supports the need for more research on synapse diversity. These conclusions are based on the authors' synthesis of current literature.

Keywords:

Alzheimer’s disease Aβ Microscopy Synapse Synaptome Tau Alzheimer's disease mechanisms synapse diversity neurodegenerative disease synaptome mapping

Frequently Asked Questions

The authors propose that Aβ and tau contribute to synapse dysfunction, though their exact roles vary across studies.

Glial cells may both protect and damage synapses in AD, according to the review.

Mitochondrial dysfunction is linked to synapse vulnerability, as noted in the literature review.

Synapse diversity may represent a new level of synapse pathology in AD, as suggested by the authors.

Synaptome mapping could help identify vulnerable and resilient synapses in AD, as discussed in the review.

The authors suggest that understanding synapse diversity may inform strategies to preserve or replenish damaged synapses.

Related Concept Videos